We are pleased to announce that we have been awarded a grant from the British Society for Antimicrobial Chemotherapy to run a large 5 year project: the UK Antimicrobial Registry.
Effective antimicrobial agents are a crucial component of modern medicine, and allow the elimination or inhibition of growth of all microorganisms. However, their effectiveness is threatened by evolutionary development of certain microbes. According to the WHO, antimicrobial resistance is increasing world-wide, and is compromising our ability to treat infectious diseases and undermining many other advances in health and medicine.
The project, which will run for five years, will construct and maintain a registry of patients receiving novel antimicrobial medication and will aim to answer a broad set of research questions around novel anti-microbial agents, describe the use of such novel agents throughout the UK, and quantify the clinical outcomes and safety profile associated with their use in a real-world setting.
Co-chief Investigator Professor Gareth Jones said:
“We are delighted to be able to develop and host this important study. It will capture real-world use of novel antimicrobials in the UK, identify areas of unmet clinical need, and help stop the growing threat of drug-resistant infections.”
The project will be led by group members Professors Gary Macfarlane, Professor Gareth Jones and Patrice Forget in conjunction with colleagues from NHS Grampian.
We are currently advertising for a Study Coordinator and Assistant Study Coordinator position to run the project. See our Job Vacancies page for details.